Limelight Networks (NASDAQ: LLNW), United Technologies Co. (NYSE: UTX), Becton Dickinson And Co (NYSE: BDX), Henry Schein, Inc. (NASDAQ: HSIC), Clean Energy Fuels Corp. (NASDAQ: CLNE) and Sykes Enterprises, Incorporated (NASDAQ: SYKE) downgraded by analysts.
Limelight Networks (LLNW) was downgraded by SunTrust (NYSE:STI) from a “Buy” rating to a “Neutral” rating.
United Technologies Co. (UTX) was downgraded by Goldman Sachs (NYSE:GS) from a “Buy” rating to a “Neutral” rating.
Becton Dickinson And Co. (BDX) was downgraded by Goldman Sachs from a “Buy” rating to a “Neutral” rating.
Henry Schein, Inc. (HSIC) was downgraded by Goldman Sachs from a “Buy” rating to a “Neutral” rating. They have a price target of $70.00 on the company.
Clean Energy Fuels Corp. (CLNE) was downgraded by Northland Securities from an “Outperform” rating to a “Market Perform” rating. They have a price target of $14.00 on the company, down from $17.00.
Sykes Enterprises, Incorporated (SYKE) was downgraded by Craig Hallum from a “Buy” rating to a “Hold” rating.
Showing posts with label Henry Schein. Show all posts
Showing posts with label Henry Schein. Show all posts
Wednesday, August 10, 2011
Limelight (LLNW) (UTX) (BDX) (HSIC) (CLNE) (SYKE) Downgraded
Labels:
Becton Dickinson,
Clean Energy Fuels,
Goldman Sachs,
Henry Schein,
Limelight,
SunTrust Banks,
Sykes Enterprises,
United Technologies
Wednesday, May 4, 2011
Price Targets on (MTW) (OII) (HSIC) (PCS) Updated by Analysts
Analysts updated price targets on Manitowoc Company, Inc. (NYSE: MTW), Oceaneering International (NYSE: OII), Henry Schein, Inc. (NASDAQ: HSIC) and MetroPCS (NYSE: PCS).
Barclays Capital (NYSE:BCS) raised their price target on Henry Schein, Inc. (HSIC) from $69.00 to $75.00. They have an “equal weight” rating on the company.
Boenning & Scattergood raised their price target on Manitowoc Company, Inc. (MTW) from $24.00 to $30.00. They have an “outperform” rating on the company.
Barclays Capital raised their price target on Oceaneering International ( OII) from $86.00 to $91.00. They have an “overweight” rating on the company.
Hudson Square Research raised their price target on MetroPCS (PCS) from $17.00 to $20.00. They have a “buy” rating on the company.
Barclays Capital (NYSE:BCS) raised their price target on Henry Schein, Inc. (HSIC) from $69.00 to $75.00. They have an “equal weight” rating on the company.
Boenning & Scattergood raised their price target on Manitowoc Company, Inc. (MTW) from $24.00 to $30.00. They have an “outperform” rating on the company.
Barclays Capital raised their price target on Oceaneering International ( OII) from $86.00 to $91.00. They have an “overweight” rating on the company.
Hudson Square Research raised their price target on MetroPCS (PCS) from $17.00 to $20.00. They have a “buy” rating on the company.
Labels:
Barclays,
Henry Schein,
Manitowoc,
MetroPCS,
Oceaneering
Price Targets on (HSIC) (MDF) (HUM) (INCY) Updated by Analysts
Analysts updated price targets on Henry Schein, Inc. (NASDAQ: HSIC), Metropolitan Health Networks, Inc. (NYSE: MDF), Humana (NYSE: HUM) and Incyte (NASDAQ: INCY).
Barrington Research raised their price target on Henry Schein, Inc. (HSIC) from $74.00 to $80.00. They have an “outperform” rating on the company.
C.K. Cooper raised their price target on Metropolitan Health Networks, Inc. (MDF) from $5.70 to $6.50. They have a “buy” rating on the company.
Barclays Capital raised their price target on Humana (HUM) from $78.00 to $85.00. They have an “equal weight” rating on the company.
Brean Murray raised their price target on Incyte (INCY) from $22.00 to $23.00. They have a “buy” rating on the company.
Barrington Research raised their price target on Henry Schein, Inc. (HSIC) from $74.00 to $80.00. They have an “outperform” rating on the company.
C.K. Cooper raised their price target on Metropolitan Health Networks, Inc. (MDF) from $5.70 to $6.50. They have a “buy” rating on the company.
Barclays Capital raised their price target on Humana (HUM) from $78.00 to $85.00. They have an “equal weight” rating on the company.
Brean Murray raised their price target on Incyte (INCY) from $22.00 to $23.00. They have a “buy” rating on the company.
Labels:
Henry Schein,
Humana,
Incyte,
Metroppolitan Health
Subscribe to:
Posts (Atom)